Benjamin R Underwood
Overview
Explore the profile of Benjamin R Underwood including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
5081
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Underwood B, Lourida I, Gong J, Tamburin S, Tang E, Sidhom E, et al.
Alzheimers Dement (N Y)
. 2025 Jan;
11(1):e70037.
PMID: 39839078
Abstract: Recent clinical trials on slowing dementia progression have led to renewed focus on finding safer, more effective treatments. One approach to identify plausible candidates is to assess whether existing...
2.
Lee L, Vaghari D, Burkhart M, Tino P, Montagnese M, Li Z, et al.
EClinicalMedicine
. 2025 Jan;
74:102725.
PMID: 39764178
Background: Predicting dementia early has major implications for clinical management and patient outcomes. Yet, we still lack sensitive tools for stratifying patients early, resulting in patients being undiagnosed or wrongly...
3.
Crowther G, Dunning R, Russell G, Wolverson E, Underwood B
BJPsych Bull
. 2024 Jul;
:1-7.
PMID: 38949259
Aims And Method: Dementia in-patient units (DIU) are mental health wards that care for people living with dementia (PLWD) whose symptoms are causing severe distress or potential risk. DIUs look...
4.
Chen S, Underwood B, Cardinal R, Chen X, Chen S, Amin J, et al.
BMC Med
. 2024 Jun;
22(1):268.
PMID: 38926751
Background: Interest in modifiable risk factors (MRFs) for dementia is high, given the personal, social, and economic impact of the disorder, especially in ageing societies such as the United Kingdom....
5.
Koychev I, Adler A, Edison P, Tom B, Milton J, Butchart J, et al.
BMJ Open
. 2024 Jun;
14(6):e081401.
PMID: 38908839
Introduction: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), currently marketed for type 2 diabetes and obesity, may offer novel mechanisms to delay or prevent neurotoxicity associated with Alzheimer's disease (AD). The...
6.
Underwood B
J Neurol Neurosurg Psychiatry
. 2024 Jun;
95(9):793.
PMID: 38862264
No abstract available.
7.
London S, Chen S, Sidhom E, Lewis J, Wolverson E, Cardinal R, et al.
Br J Psychiatry
. 2024 May;
224(6):221-229.
PMID: 38738348
Background: Dementia is a common and progressive condition whose prevalence is growing worldwide. It is challenging for healthcare systems to provide continuity in clinical services for all patients from diagnosis...
8.
Thompson N, Hsu M, Odell-Miller H, Underwood B, Wolverson E
BMC Geriatr
. 2024 Apr;
24(1):364.
PMID: 38654223
Background: The National Institute for Health and Care Excellence guidelines state that psychosocial interventions should be the first line of treatment for people with dementia who are experiencing distress behaviours,...
9.
Laurell A, Venkataraman A, Schmidt T, Montagnese M, Mueller C, Stewart R, et al.
Br J Psychiatry
. 2024 Jan;
224(6):198-204.
PMID: 38235531
Background: Phase three trials of the monoclonal antibodies lecanemab and donanemab, which target brain amyloid, have reported statistically significant differences in clinical end-points in early Alzheimer's disease. These drugs are...
10.
Smith L, Yon D, Butler L, Kostev K, Brayne C, Barnett Y, et al.
J Phys Act Health
. 2023 Dec;
21(3):247-255.
PMID: 38154018
Background: There is a scarcity of studies on the association between physical multimorbidity and lower levels of physical activity among older adults from low- and middle-income countries, while the potential...